Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:38 pm Purchase | 2024-12-31 | 13G | Upstream Bio, Inc. UPB | Decheng Capital Global Life Sciences Fund IV L.P. | 3,285,293 6.100% | 3,285,293 (New Position) | Filing History |
| 2025-02-14 4:23 pm Purchase | 2024-12-31 | 13G | Upstream Bio, Inc. UPB | TCG Crossover GP I, LLC | 2,801,763 5.200% | 2,801,763 (New Position) | Filing History |
| 2025-02-13 4:16 pm Purchase | 2024-12-31 | 13G | Upstream Bio, Inc. UPB | HBM Healthcare Investments (Cayman) Ltd. | 2,715,056 5.100% | 2,715,056 (New Position) | Filing History |
| 2025-02-12 09:34 am Purchase | 2024-12-31 | 13G | Upstream Bio, Inc. UPB | FMR LLC | 7,176,187 13.400% | 1,106,311 (+18.23%) | Filing History |
| 2024-11-07 09:24 am Purchase | 2024-11-06 | 13G | Upstream Bio, Inc. UPB | FMR LLC | 6,069,876 11.822% | 6,069,876 (New Position) | Filing History |
| 2024-10-22 4:06 pm Purchase | 2024-10-15 | 13D | Upstream Bio, Inc. UPB | AI Upstream LLC | 5,494,410 10.700% | 5,494,410 (New Position) | Filing History |
| 2024-10-18 6:10 pm Purchase | 2024-10-15 | 13G | Upstream Bio, Inc. UPB | BCLS Fund III Investments, LP | 2,295,322 4.300% | 2,295,322 (New Position) | Filing History |
| 2024-10-17 4:16 pm Purchase | 2024-10-15 | 13D | Upstream Bio, Inc. UPB | ORBIMED ADVISORS LLC | 4,554,873 8.900% | 4,554,873 (New Position) | Filing History |